Beone Medicines Ltd (ONC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,600,523 | -950,578 | -674,033 | -93,299 | -119,217 |
| Depreciation Amortization | 31,789 | 18,617 | 10,388 | 4,758 | 1,909 |
| Income taxes - deferred | -27,807 | -9,232 | -21,949 | -5,845 | -768 |
| Accounts receivable | 10,363 | -29,822 | -11,628 | -29,428 | N/A |
| Accounts payable and accrued liabilities | 95,835 | 2,224 | 23,470 | 55,298 | 2,707 |
| Other Working Capital | 150,584 | -10,833 | -17,214 | 57,199 | 14,888 |
| Other Operating Activity | 56,298 | 229,355 | 143,249 | 24,069 | 10,968 |
| Operating Cash Flow | $-1,283,461 | $-750,269 | $-547,717 | $12,752 | $-89,513 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -117,508 | -89,612 | -108,581 | -46,374 | -23,498 |
| Purchase Of Investment | -26,681 | -1,169,300 | -2,635,686 | -741,296 | -382,093 |
| Sale Of Investment | 2,751,075 | 1,882,075 | 2,177,207 | 423,789 | 183,743 |
| Purchase Sale Intangibles | N/A | N/A | -553 | -12,354 | N/A |
| Other Investing Activity | -5,775,252 | -69,000 | -70,553 | 7,562 | 0 |
| Investing Cash Flow | $-3,168,366 | $554,163 | $-637,613 | $-356,319 | $-221,848 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 323,697 | 67,489 | N/A | 2,470 | N/A |
| Debt Issued | 110,208 | N/A | 42,315 | 132,757 | 12,048 |
| Debt Repayment | -160,784 | N/A | -8,736 | N/A | N/A |
| Common Stock Issued | 4,325,118 | 47,004 | 1,663,031 | 343,746 | 371,072 |
| Other Financing Activity | 604,587 | -28,813 | -6,073 | 11,383 | -2,218 |
| Financing Cash Flow | $5,202,826 | $85,680 | $1,690,537 | $490,356 | $380,902 |
| Exchange Rate Effect | 18,231 | -9,512 | -4,096 | 5,299 | 104 |
| Beginning Cash Position | 620,775 | 740,713 | 239,602 | 87,514 | 17,869 |
| End Cash Position | 1,390,005 | 620,775 | 740,713 | 239,602 | 87,514 |
| Net Cash Flow | $769,230 | $-119,938 | $501,111 | $152,088 | $69,645 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,283,461 | -750,269 | -547,717 | 12,752 | -89,513 |
| Capital Expenditure | -117,508 | -89,612 | -108,581 | -46,374 | -23,502 |
| Free Cash Flow | -1,400,969 | -839,881 | -656,298 | -33,622 | -113,015 |